158 related articles for article (PubMed ID: 9082290)
1. [Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities].
Klivényi P; Vécsei L
Orv Hetil; 1997 Feb; 138(6):331-5. PubMed ID: 9082290
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Fernández-Ruiz J; Romero J; Ramos JA
Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
[TBL] [Abstract][Full Text] [Related]
3. Neuropharmacology of degenerative diseases associated with aging.
Growdon JH
Med Res Rev; 1983; 3(3):237-57. PubMed ID: 6136638
[No Abstract] [Full Text] [Related]
4. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF
Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
[TBL] [Abstract][Full Text] [Related]
5. Benefits of curcumin in brain disorders.
Bhat A; Mahalakshmi AM; Ray B; Tuladhar S; Hediyal TA; Manthiannem E; Padamati J; Chandra R; Chidambaram SB; Sakharkar MK
Biofactors; 2019 Sep; 45(5):666-689. PubMed ID: 31185140
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.
Alexi T; Borlongan CV; Faull RL; Williams CE; Clark RG; Gluckman PD; Hughes PE
Prog Neurobiol; 2000 Apr; 60(5):409-70. PubMed ID: 10697073
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological differences between subtypes of dementia.
Goodin DS; Aminoff MJ
Brain; 1986 Dec; 109 ( Pt 6)():1103-13. PubMed ID: 2947660
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases.
Pérez-Olives C; Rivas-Santisteban R; Lillo J; Navarro G; Franco R
Adv Exp Med Biol; 2021; 1264():81-92. PubMed ID: 33332005
[TBL] [Abstract][Full Text] [Related]
9. Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?
Jodeiri Farshbaf M; Ghaedi K
Biometals; 2017 Feb; 30(1):1-16. PubMed ID: 27853903
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
[TBL] [Abstract][Full Text] [Related]
11. Role of excitotoxins in heredito-degenerative neurologic diseases.
Young AB
Res Publ Assoc Res Nerv Ment Dis; 1993; 71():175-89. PubMed ID: 8093331
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological features of the dementia of Parkinson's disease.
Aminoff MJ; Goodin A; Goodin DS
Adv Neurol; 1990; 53():361-3. PubMed ID: 2146859
[No Abstract] [Full Text] [Related]
13. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
Antal A; Bodis-Wollner I
Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid System in Neurological Disorders.
Ranieri R; Laezza C; Bifulco M; Marasco D; Malfitano AM
Recent Pat CNS Drug Discov; 2016; 10(2):90-112. PubMed ID: 27364363
[TBL] [Abstract][Full Text] [Related]
15. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
Schapira AH; Olanow CW; Greenamyre JT; Bezard E
Lancet; 2014 Aug; 384(9942):545-55. PubMed ID: 24954676
[TBL] [Abstract][Full Text] [Related]
16. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
17. Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.
Kornhuber J; Weller M
Biol Psychiatry; 1997 Jan; 41(2):135-44. PubMed ID: 9018383
[TBL] [Abstract][Full Text] [Related]
18. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
20. Clinical neurophysiology of aging and dementia.
Pedley TA; Miller JA
Adv Neurol; 1983; 38():31-49. PubMed ID: 6225316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
